CS
HURA

Credit Suisse’s TuHURA Biosciences HURA Stock Holding History

Credit Suisse’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed -$9K – 4032
2018
Q2 		$9K Hold
1
– – ﹤0.01% 3939
2018
Q1 		$13K Hold
1
– – ﹤0.01% 3932
2017
Q4 		$14K Hold
1
– – ﹤0.01% 3946
2017
Q3 		$11K Buy
+1
New +$27.4K ﹤0.01% 4161

Other funds holding HURA

LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Credit Suisse's HURA Position: Q3 2018 in Review

Credit Suisse sold out of TuHURA Biosciences (HURA) in Q3 2018, closing a stake of 1 share — an estimated $9K sold.

Credit Suisse first reported a position in HURA in Q3 2017 and held it in 4 quarters. The position peaked at $14K in Q4 2017. 5 funds tracked by Wall St. Rank hold HURA as of Q3 2018.

  • Credit Suisse reported no remaining TuHURA Biosciences position as of Q3 2018 after selling out during the quarter.
  • Credit Suisse sold 1 TuHURA Biosciences share in Q3 2018, an estimated $9K.
  • Credit Suisse first reported a position in TuHURA Biosciences in Q3 2017 and held it in 4 quarters.
  • Credit Suisse's TuHURA Biosciences position peaked at $14K in Q4 2017.
  • 5 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q3 2018.

Based on Credit Suisse's 13F filing for Q3 2018, filed 13 Nov 2018.